Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of ...
Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback